Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-24T04:43:14.383Z Has data issue: false hasContentIssue false

A retrospective survey of fibrinolysis as an indicator of poor outcome after cardiopulmonary bypass and a possible early sign of systemic inflammation syndrome

Published online by Cambridge University Press:  16 August 2006

K. Cvachovec
Affiliation:
Department of Anaesthesiology and Critical Care Medicine and Second School of Medicine Charles University and Postgraduate School of Medicine Praha
M. Horáček
Affiliation:
Department of Anaesthesiology and Critical Care Medicine and Second School of Medicine Charles University and Postgraduate School of Medicine Praha
I. Vislocký
Affiliation:
Department of Adult Cardiac Surgery, University Hospital Motol, V úvalu 84, 150 06 Praha 5, Czech Republic
Get access

Abstract

A retrospective survey was undertaken of 142 adults who had undergone cardiac surgery with cardiopulmonary bypass. According to the manufacturer's instructions for thromboelastography, patients were identified as showing evidence of fibrinolysis if after coming off bypass the Ly30 index was ≥7.5%. In the 20 fibrinolytic patients, fibrinolysis was readily corrected by tranexamic acid but these patients needed more colloid and more vasopressor support than the non-fibrinolytic patients. There were three deaths, all in the fibrinolytic patients. It is possible that fibrinolysis is a marker for onset of systemic inflammation syndrome. It is recommended that, until the association between fibrinolysis and worse outcome is investigated further, patients showing fibrinolysis early after cardiopulmonary bypass should not be discharged too soon from intensive care.

Type
Original Article
Copyright
2000 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)